Articles dans des revues avec comité de lecture (81)
49.
Najar, M., Rouas, R., Raicevic, G., Boufker, H. I., Lewalle, P., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., Martiat, P., & Lagneaux, L. (2009). Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy, 11(5), 570-583. doi:10.1080/1465324090307937750.
Ciceri, F., Labopin, M., Aversa, F., Rowe, J., Bunjes, D., Lewalle, P., Nagler, A., Di Bartolomeo, P., Lacerda, J. F., Lupo Stanghellini, M. T., Polge, E., Frassoni, F., Martelli, M., & Rocha, V. (2008). A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood, 112(9), 3574-3581. doi:10.1182/blood-2008-02-14009551.
Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica, 93(1), e11-e13. doi:10.3324/haematol.1180252.
Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stromal Cell (MSC) infusion for the Treatment of Metachromatic Leukodystrophy (MLD): A case report. Haematologica, 93(1), 48.54.
Dehan, P., Couvreur, B., Hamers, C., Lewalle, P., Thiry, E., Kerkhofs, P., & Pastoret, P.-P. (2005). Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny. Vaccine, 23(33), 4236-4246. doi:10.1016/j.vaccine.2005.03.02655.
Rouas, R., Lewalle, P., El Ouriaghli, F., Nowak, B., Duvillier, H., & Martiat, P. (2004). Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. International immunology, 16(5), 767-773. doi:10.1093/intimm/dxh07756.
Lewalle, P., Delforge, A., Aoun, M., Crombez, P., De Wilde, V., Theunissen, K., Lagneaux, L., Nowak, B., Misplon, V., Bron, D., & Martiat, P. (2004). Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management. Blood cells, molecules, & diseases, 33(3), 256-260. doi:10.1016/j.bcmd.2004.08.01258.
Hamers, C., Couvreur, B., Dehan, P., Letellier, C., Fischer, L., Brun, A., Lewalle, P., Michaux, C., Pastoret, P.-P., & Kerkhofs, P. (2003). Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge. Veterinary record, 153(8), 236-240.59.
Lewalle, P., Triffet, A., Delforge, A., Crombez, P., Selleslag, D., De Muynck, H., Bron, D., & Martiat, P. (2003). Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone marrow transplantation, 31(1), 39-44. doi:10.1038/sj.bmt.170377960.
Rouas, R., Uch, R., Cleuter, Y., Jordier, F., Bagnis, C., Mannoni, P., Lewalle, P., Martiat, P., & Van Den Broeke, A. (2002). Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer gene therapy, 9(9), 715-724. doi:10.1038/sj.cgt.7700500